Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study-Reference-Cited by-同舟云学术

Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS study

Published:2018-03-01 Issue:6 Volume:20 Page:1419-1426
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Malmström Håkan¹²^ORCID,Walldius Göran¹,Carlsson Sofia¹,Grill Valdemar³⁴,Jungner Ingmar²⁵,Gudbjörnsdottir Soffia⁶,Kosiborod Mikhail⁷,Hammar Niklas¹⁸

Affiliation:

1. Unit of Epidemiology; Institute of Environmental Medicine, Karolinska Institute; Stockholm Sweden

2. Swedish Orphan Biovitrum AB; Stockholm Sweden

3. Department of Clinical and Molecular Medicine; Norwegian University of Science and Technology; Trondheim Norway

4. Department of Endocrinology; Trondheim University Hospital; Trondheim Norway

5. CALAB Research; Stockholm Sweden

6. Department of Medicine, Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

7. Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City; Kansas City Missouri

8. Medical Evidence and Observational Research, Global Medical Evidence and Observational Research, AstraZeneca; Gothenburg Sweden

Funder

Gunnar and Ingmar Jungner Foundation for Laboratory Medicine

Fondation pour la Médecine de Laboratoire

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13241/fullpdf

Reference27 articles.

1. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes;Lyssenko;J Clin Invest,2007

2. The many faces of diabetes: a disease with increasing heterogeneity;Tuomi;Lancet,2014

3. Triglyceride levels and risk of type 2 diabetes mellitus: a longitudinal large study;Beshara;J Invest Med,2016

4. A lifestyle intervention in primary care prevents deterioration of insulin resistance in patients with impaired glucose tolerance: a randomised controlled trial;Hellgren;Scand J Public Health.,2016

5. Risk models and scores for type 2 diabetes: systematic review;Noble;BMJ,2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of the Metabolic Score for Insulin Resistance in the development of myocardial infarction in patients with coronary artery disease and obesity after coronary stenting;Russian Journal of Cardiology;2022-05-23

2. Alterations in Biomarkers Related to Glycemia, Lipid Metabolism, and Inflammation up to 20 Years Before Diagnosis of Type 1 Diabetes in Adults: Findings From the AMORIS Cohort;Diabetes Care;2021-12-07

3. Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study;PLOS Medicine;2021-12-01

4. Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure;Cardiovascular Diabetology;2021-11-24

5. Glucose Effectiveness Decreases in Relationship to a Subtle Worsening of Metabolic Parameters in Young Japanese with Normal Glucose Tolerance;Metabolic Syndrome and Related Disorders;2021-09-01